SCHEDULE: Nantahala Capital Discloses 9.99% Stake in Apyx Medical

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, reported a 9.99% beneficial ownership stake in Apyx Medical Corporation as of December 31, 2025.

Summary

• Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack (the "Reporting Persons") collectively reported beneficial ownership of 4,112,705 shares of Apyx Medical Corporation's Common Stock.
• This ownership represents 9.99% of the total class of securities outstanding.
• The reported shares include 138,614 shares that may be acquired by the Reporting Persons within sixty days through the exercise of warrants.
• The Reporting Persons hold shared voting power and shared dispositive power over all 4,112,705 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as moderately positive, indicating significant institutional interest and a substantial stake in Apyx Medical, which can be a sign of investor confidence.

Positives

• Significant institutional ownership by Nantahala Capital Management, an investment adviser, may signal confidence in Apyx Medical's future prospects.
• The stake represents a substantial commitment from a sophisticated investor group.

Risks

• The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating immediate control-related risks from this specific filing.

Future Outlook

This filing is an ownership disclosure and does not contain forward-looking statements or guidance regarding the company's financial performance or strategic direction.

Industry Context

StockSavvy.ai notes that significant institutional ownership, especially from an investment adviser like Nantahala Capital Management, often signals a vote of confidence in a company's long-term prospects and strategic direction within the medical technology sector. Such disclosures can attract further investor attention to Apyx Medical.

Stakeholder Impact

• Shareholders may perceive the increased institutional ownership as a positive indicator of investor confidence and potential stability in the stock.
• The disclosure could lead to increased scrutiny and analysis of Apyx Medical by other institutional investors.

Key Dates

Recommendation

The disclosure of a significant 9.99% stake by an investment adviser like Nantahala Capital Management suggests institutional confidence in Apyx Medical. However, without additional financial or operational updates, this filing primarily serves as an ownership update rather than a catalyst for a strong buy or sell recommendation. It warrants a 'hold' for current investors and further due diligence for prospective investors.

Keywords

Apyx Medical Corporation, Nantahala Capital Management, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Schedule 13G, Medical Technology